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A new technique of extensive surgical intervention, namely nerve sparing radical hysterectomy (NSRH),
was introduced as one of the treatment options for early stage cervical cancer patients because cervical
cancer patients suffer from postoperative complications following radical hysterectomy procedure. The
step of nerve preservation can reduce postoperative complications, such as bladder or sexual dysfunction
problems that occur after a traditional radical hysterectomy procedure. The surgical outcomes seem to be
favorable and no serious morbidity was noted. However, further study of the nerve sparing technique is
necessary to improve this surgical advantage in the future.
Copyright  2013, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Radical hysterectomy has been beneﬁcial since Ernst Wertheim
published the technique in 1911.1 Meigs improved the effectiveness
of the Wertheim radical hysterectomy technique in the 1940s, by
combination with a pelvic node dissection procedure.2 Moreover,
ﬁve classes of the Piver-Rutledge-Smith extended hysterectomy
became the most commonly used classiﬁcation for this gynecologic
oncology operation since 1974.3 The Type III radical hysterectomy
procedure is considered to be one of the treatment options for
patients with early stage cervical carcinoma; more than 100 years
ago, extensive tissue dissection was necessary. Surgical-related
complications always occur; not only intraoperative complica-
tions, but also postoperative complications, such as urinary-rectal
dysfunction and sexual dysfunction.4 Furthermore, as reported by
Fujii et al,5 Okabayashi ﬁrst introduced radical hysterectomy in
Japan in 1921, and in 1944 repeatedly published that the nerve
preservation method would be advantageous over the traditional
radical hysterectomy procedure, in order to reduce the vast oper-
ative morbidity andmortality rates. This operative technique seems
to have the beneﬁts of a minimally invasive method. Unfortunately,
although there are several studies of the nerve sparing technique in
the radical hysterectomy procedure, few studies have beenand Gynecology, Chang Gung
g Gung University, College of
, Taiwan.
uang).
ia-PaciﬁcAssociationforGynecologicEpublished. This article reviews the value of nerve-sparing radical
hysterectomy (NSRH) in cervical cancer studies.
Anatomical location of radical hysterectomy-related nerves
One of the neural tissue networks, the presacral nerve, is the part
of the pelvic autonomic nervous system in the presacral space.6 A
retroperitoneal ganglionic midline plexus, which lies on the ventral
surface of the lower aorta, is termed the superior hypogastric plexus.
These neural tissues split into two trunks of hypogastric nerves,
passing the bifurcationof aorta anddescending into the pelvis. At the
region of internal iliac vessels, the inferior hypogastric plexus (Fig.1)
is developed by nerve ﬁbers of the sympathetic chain from the 10th
thoracic plexus and parasympathetic ﬁbers from the second, third,
and fourth sacral nerves, via the pelvic splanchnic nerve route
merged to the hypogastric nerve expansion.6 In particular, the ute-
rovaginal plexus (Frankenhäuser ganglion; one of three portions of
the inferior hypogastric plexus that locates themedial to the uterine
blood vessels and the lateral to the uterosacral ligaments) sends
neuralﬁbers to innervate theuterus andurinarybladder.5,6 Extensive
tissue resection, including these nerve ﬁbers, was necessary during
the radical hysterectomy procedure. Therefore, postoperative com-
plications always occurred.
Patient characteristics affecting the NSRH procedure
There are many different terms used to describe nerve preser-
vation during the radical hysterectomy procedure, however, theyndoscopyandMinimally InvasiveTherapy.PublishedbyElsevierTaiwanLLC.All rightsreserved.
Fig. 1. Inferior hypogastric plexus. B ¼ bladder branch of inferior hypogastric plexus; H ¼ hypogastric nerve; L ¼ left side; R ¼ right side; S ¼ pelvic splanchnic nerve; T ¼ inferior
hypogastric plexus.
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From the published data of nerve sparing radical hysterectomy, in
general, patients’ data such as age and clinical FIGO staging are
similar (Table 1).5,7e20 Almost all of the study populations are
cervical cancer patients, but other tumors (e.g., vaginal cancer and
endometrial cancer) are also included in the NSRH studies.7,10,12
Surgical interventions of both laparotomy5,7e17 and laparos-
copy18e20 can be considerable. In a study by Trimbos et al,8 the
nerve sparing operation was performed unsuccessfully in two of 10
patients, because there is greater fatty conﬁguration in western as
compared to eastern populations. This is similar to a report by
Raspagliesi et al,9 who experienced a troublesome NSRH procedure
in a patient who had a body mass index (BMI) >30 kg/m2. Unfor-
tunately, in these two studies, laparotomy was involved. Until now,
the correlation of BMI and the laparoscopic method in NSRH
studies has not been reported. In addition, Trimbos et al8 also noted
that tumor size is one of the factors that affects achievement in the
nerve sparing radical hysterectomy procedure,11,13,15 but studies do
not reveal statistically signiﬁcant results.Table 1
General patients’ characteristics.
Reference Age (y) BMI (kg/m2) Tumor diameter (
Fujii et al5 24e72 21.0 (16.4e28.8) 3.15 (0.75e11.0)
Höckel et al7 30e58 e 1.5e5.7
Trimbos et al8 29e69 15e32 2e7
Raspagliesi et al9 28e60 17.4e35.2 e
Ito and Saito10 e e e
Sakuragi et al11 35e60 [NS]
31e64 [non-NS]
e 1.1e7.0 (median 3
1.2e5.0 (median 3
Charoenkwan et al12 28e59 25.06 (17.8e35.2) 2.4
Raspagliesi et al13 28e76 24.3 (15.8e40.8) 2.44 (22.7e26.1)
2.39 (22.8e25.0)
2.53 (23.6e27.0)
Kato et al14 28e65 22.1 (16.2e34.4) > 2.0
van den Tillaart et al15 23e80 [NS]
25e81 [non-NS]
e 24.8%
18.3% (>4.0 cm)
Höckel et al16 24e79 25 (15e40) 3.0 (0.7e10.0)
Höckel17 24e77 24 (15e35) 2.7 (0.7e10.0)
Possover et al18 e e e
Querleu et al19 e e e
Possover20 e e e
BMI ¼ body mass index; BNS ¼ bilateral nerve sparing; CR ¼ complete response; FIGO
NACT ¼ neoadjuvant chemotherapy; NS ¼ nerve sparing; type II ¼ radical hysterectomy
hysterectomy type III; UNS ¼ unilateral nerve sparing.NSRH procedure affected operation outcome and bladder
function
From Table 2,5,7e16,18e20 it can be seen that most of the pub-
lished papers demonstrated corresponding outcomes in terms of
the mean operating time and blood loss, which revealed non-
statistically different results, even though the NSRH procedure in a
study by Sakuragi et al11 was recorded as being >2 hours longer
than the non-nerve sparing procedure. Sakuragi et al explained that
their hospital is a medical university institute, which may be the
reason for this result. Some extensive surgery may lead to a degree
of complications during any step of the operation, even if no serious
events were identiﬁed.21,22 Furthermore, a short operative time for
specimen removal via the vaginal approach in the laparoscopic
study20 was also reported.
Many published studies demonstrated long term urinary
dysfunction, which is one of themost common complications in the
conventional radical hysterectomy procedure for cervical cancer
treatment.21e25 Thus,NSRHstudies attempt to showwhetherneuralcm) Type of tumor (n) FIGO staging Number of patients (n)
Total NS Non-NS
Cervix IBeIIA 24 24 e
Cervix (6)
Vagina (1)
IBeIIB
IIB
7 7 e
Cervix e 10 8 2
Cervix IB1eIIB 23 23 e
Cervix (23)
Endometrium (2)
IB1eIIB
IIB
25 25 e
.9 cm)
.4 cm)
Cervix IB1eIIB 27 22 5
Cervix (21)
Endometrium (1)
IBeIIA
II [Clinical stage]
22 22 e
Cervix
type II (31)
type III-NS (59)
type III (20)
IA2eCR if NACT 110 110 e
Cervix
UNS/BNS (11/21)
IBeIIB 32 32 e
Cervix IAeIIA 246 122 124
Cervix IBeIIB 212 212 e
Cervix IBeIIB 163 163 e
Cervix IB1eIIIA 64 38 28
Cervix IA2eII 95 47 48
Cervix IBeIIB 32 32 e
¼ International Federation of Gynecology and Obstetrics; n ¼ number of patients;
type II; type III ¼ radical hysterectomy type III; type III-NS ¼ nerve sparing radical
Table 2
Intraoperative data.
Reference Mean operating time (min) Mean blood loss (mL) Average duration for
bladder drainage (day)
Average length of
hospitalization (day)
Fujii et al5 e e 14.64 (2.04) e
Höckel et al7 e 800 (500e1500) 12 (8e30) e
Trimbos et al8 180e240 510e1700 5e7 9 (8e11)
Raspagliesi et al9 219 (150e270) 489 (200e800) 4e28 10 (5e16)
Ito and Saito10 e e 17.1 (6.4) e
Sakuragi et al11 NS 515 (387e791) 1400 (640e4185) e e
Non-NS 370 (345e648) 1160 (450e2400) e e
Charoenkwan et al12 220 (180e270) 510 (200e1300) 11.27 (5e26) e
Raspagliesi et al13 type II 175 224 e 7.4 (6.8e8.0)
type III-NS 210 421 9.0 (8.6e9.9)
type III 224 434 9.1 (8.3e10.0)
Kato et al14 UNS 343 (272e548) 736 (238e1380) 11.5 (5e21) e
BNS 5.3 (1e14)
van den Tillaart et al15 NS 174 (60e270) 840 (125e4500) 5 (3e29) 7.0 (5e32)
Non-NS 192 (120e330) 1115 (175e11000) e e
Höckel et al16 426 (306e696) e 9 (6e29) 12 (5e24)
Possover et al18 NS e e 11.2 (6e20  4.3) e
Non-NS e e 21.4 (7e47  11.3) e
Querleu et al19 NS * 228 391 1 or 2 e
Non-NS ** 233 272
Possover20 167 (135e195) (þonly P&PM LD) e e e
202 (181e215) (þPA LD)
BNS ¼ bilateral nerve sparing; FIGO ¼ International Federation of Gynecology and Obstetrics; NS ¼ nerve sparing; NS * ¼ radical hysterectomy with paracervical dissection;
Non-NS ** ¼ radical hysterectomy without paracervical dissection; PA LD ¼ para-aortic lymphadenectomy; P&PM LD ¼ pelvic and parametric lymphadenectomy; type
II ¼ radical hysterectomy type II; type III ¼ radical hysterectomy type III; type III-NS ¼ nerve sparing radical hysterectomy type III; UNS ¼ unilateral nerve sparing.
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et al18 studied 38 cervical cancer patients undergoing the nerve-
sparing laparoscopic-assisted radical vaginal hysterectomy Type
III, and 28 patients undergoing the non-nerve sparing operation.
They revealed a statistically signiﬁcant result (p¼0.0007) of bladder
drainage duration between 11.2 days (6e20,4.3) in nerve-sparing
and 21.4 days (7e47, 11.3) in non-nerve sparing groups, even
though the urinary retention outcome was discovered in some
nerve-sparing patients.19 Thus, bladder drainage duration in the
NSRH procedurewas recorded as varying from approximately 1 to 4
weeks5,7e10,12,14e16,18,19; individual bladder training policy may be
one of the affecting factors. The value of the bilateral nerve-sparing
procedure was also signiﬁcantly demonstrated by Kato et al.14 The
urinary catheter could be removed in patients in whom NSRH was
performed bilaterally, within 5.3 days, compared with 11.5 days in
the unilateral group (p¼ 0.004). Furthermore, early improvement in
bladder function data, in terms of patients who could be discharged
without self-catheterization13,14 was also reported. After the T-
shape inferior hypogastric plexus preservation technique was pub-
lished in 2007, Fujii and colleagues5 revealed a successful study, not
only in terms of bladder function, but also in terms of bladder full-
ness sensation and satisfactory micturition. The authors reported
that 91.7% of patients gained the bladder fullness sensation 5 days
after removal of the catheter, and 17 patients (70.8%) had early
satisfactory micturition within 14 postoperative days; both func-
tions completely recovered within 3 weeks.
Operative complications in NSRH
Considering early complications, many nerve-sparing radical
hysterectomy studies recorded various complications that seem
similar to the conventional methods, as shown in Table 3.7e9,11e17,19
Most complications are mild and manageable. Raspagliesi and
colleagues13 unveiled a comparative study of complications be-
tween Type II, nerve-sparing Type III, and conventional Type III
radical hysterectomy. They experienced Grade III/IV ureteral com-
plications data or perioperative complications of 10%, 17%, and 15%,
respectively; there was no statistically signiﬁcant differencebetween the groups. The authors concluded that the NSRH proce-
dure is comparable to the Type II radical hysterectomy, however, in
terms of early bladder dysfunction, it appears superior to the Type
III conventional style. Moreover, after a 1-year follow-up period,
Sakuragi et al11 stated in their study that no incontinence problems
developed in 22 of 27 preserved-nerve patients. By contrast,
Querleu and colleagues19 discovered signiﬁcantly different post-
operative urinary retention rates in laparoscopic vaginal radical
hysterectomy, with 36% of the preserved nerve compared to 10.4%
of the non-preserved nerve procedure; the immediate splanchnic
nerve surrounding tissue edema was described to be the reason.
Pathologic risk factors in the NSRH procedure
The histopathological factors in the NSRH study are outlined in
Table 4.7e9,11e17,19 The average number of removed pelvic nodes
was about 30e70; the peri-aortic node count are also mentioned.
Lymph node metastasis, lymphovascular space invasion (LVSI), and
parametrial invasion were 5e26%, 40e50%, and 10e20%, respec-
tively. Raspagliesi et al13 and van den Tillaart et al15 demonstrated
the resemblance of risk factors in cervical cancer patients who
underwent NSRH and non-NSRH. No signiﬁcant differences were
noted.26,27
Recurrence status and survival rate in the NSRH procedure
Concerning the relationship between prognostic factors and
survival, several published studies reported that the risk factors of
cervical cancer were related to the recurrent status and survival
rate for patients with cervical carcinoma who were treated by
standard management,28e30 such as adenocarcinoma histological
type, tumor size, lymphovascular invasion, lymph node metastasis,
and parametrial involvement. The NSRH study also disclosed these
outcomes. Unfortunately, the preservative nerve technique
including laparotomy and laparoscopy is a new strategy, from the
past 10 years, and notmuch survival outcome information has been
reported. The details are shown in Table 5.11,15–17,19 The recurrent
disease occurred at local-regional and/or distantmetastasis, but not
Table 3
Complications data.
Reference Intraoperative
complications
(n or %)
Postoperative complications (n or %) Late complications
Höckel et al7 0 e e
Trimbos et al8 e 5 e
Raspagliesi et al9 0 6 e
Sakuragi et al11 NS
Non-NS
e
e
e
e
1 y post surgery
0
3 (urinary incontinence)
3 (reduced desire to void,
abnormal bladder sensation)
Charoenkwan et al12 1 e e
Raspagliesi et al13 type II
type III-NS
type III
Grade III/IV
complication
3 (10%)
10 (17%)
3 (15%)
Minor grade:
6
10
4
Major grade
3
11
3
Grade III/IV ureteral complications
and ureteral ﬁstula rate: 5.4% and 3.6%
Kato et al14 UNS e 3 e
BNS e 6 e
van den Tillaart
et al15
NS e 7.5% (UTI), 6.7% (fever), 2.5% (RTI) e
Non-NS e e
Höckel et al16 e 132 (62%) (no complication)
74 (35%) (grade 1)
20 (9%) (grade 2)
e
Höckel17 e 74 (minor grade) e
Querleu et al19 NS*
Non-NS**
e
e
Post-op comp
7
4
U retention (>100 mL)
17 (36%)
5 (10.4%)
Duration (days)
16 (1e330)
11 (3e21)
No U sympt
4/32 (12.5%)
4/28 (14%)
1 mod or sev sympt
15/32 (47%)
13/28 (46%)
Sev sympt
6/32 (19%)
5/28 (18%)
BNS ¼ bilateral nerve sparing; FIGO ¼ International Federation of Gynecology and Obstetrics; mod ¼ moderate; n ¼ number of patients; Non-NS ** ¼ radical hysterectomy
without paracervical dissection; NS ¼ nerve sparing; NS * ¼ radical hysterectomy with paracervical dissection; P&PM LD ¼ pelvic and parametric lymphadenectomy; post-op
comp¼ postoperative complication; RTI¼ respiratory tract infection; sev¼ severe; sympt¼ symptoms; type II¼ radical hysterectomy type II; type III¼ radical hysterectomy
type III; type III-NS ¼ nerve sparing radical hysterectomy type III; U ¼ urinary; UNS ¼ unilateral nerve sparing; UTI ¼ urinary tract infection.
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ease free survival and overall survival data were not revealed to be
lower than for conventional radical surgery.28,29 In a comparative
study, the authors showed a 2-year disease free survival rate of
95.5% in the preserved nerve group, compared to 100% in the non-
nerve sparing group11; there was no statistical difference in the 5-
year overall survival rate between the two groups.15 In addition,
Höckel and colleagues16,17 studied the total mesometrial resectionTable 4
Pathologic risk factors.
Reference Number of lymph nodes LN me
Höckel et al7 33e76 1
Trimbos et al8 e 2
Raspagliesi et al9 43 (18e69) 5/23 (2
Sakuragi et al11 NS e 4/22
Non-NS e 0/5
Charoenkwan et al12 27 (16e42) 1 (5%)
Raspagliesi et al13 type II e e
type III-NS e e
type III e e
Kato et al14 UNS e 14/32
BNS e
van den Tillaart et al15 NS 22 (6e45) 26.2%
Non-NS 17 (5e33) 16.9%
Höckel et al16 44 (15e104) (PL)
10 (4e31) (PA)
44 (PL
12 (PA
Höckel17 46 (12) (PL) 32 (20
11 (7) (PA) 7 (4%)
Querleu et al19 NS* 19 (6e46)/6 (0e18) (IL/PM) 4/1 (IL
Non-NS** 18 (4e45)/0 (IL/PM) 2/0 (IL
BNS ¼ bilateral nerve sparing; FIGO ¼ International Federation of Gynecology and Obstet
n ¼ number of patients; NS ¼ nerve sparing; NS* ¼ radical hysterectomy with paracerv
PA ¼ periaortic lymph node; PC ¼ paracervical node; PL ¼ pelvic lymph node; PM ¼ para
type III; type III-NS ¼ nerve sparing radical hysterectomy type III; UNS ¼ unilateral nerv(TMMR) technique, which is the removal of the embryologically
uterovaginal (Müllerian) compartment. They demonstrated satis-
factory 3-year and 5-year survival outcomes, which were related to
histopathological factors. Höckel and colleagues explained that this
new operative technique could be the reason for the favorable re-
sults. When the recurrent disease location was considered, the
authors showed that this technique can explore the rich lymph
nodes areas, which traditional radical hysterectomy can not.16tastasis, n (%) LVSI, n (%) Parametrial invasion, n (%)
e e
e 1
2%) 11/23 (48%) 3
17/22 e
3/5 e
6 (27%) 3 (14%)
16 (51.6%) 3/31 (10%)
26 (44%) 13/59 (22%)
10 (50%) 4/20 (20%)
(total) 20/32 (total) 9/11
e
37.7% 7.4%
34.9% 7.3%
)
)
136 (lymphatic)
22 (vascular)
52 (25%) (subperitoneal mesometrium)
29 (14%) (uterine corpus)
12 (6%) (proximal vagina)
2 (fallopian tubes)
1 (middle vagina)
%) (PL) 98 (lymphatic) e
(PA) 14 (vascular)
/PC) 11 2
/PC) 13 1
rics; IL ¼ interiliac node; LN ¼ lymph node; LVSI ¼ lymphovascular space invasion;
ical dissection; Non-NS** ¼ radical hysterectomy without paracervical dissection;
metrial node; type II ¼ radical hysterectomy type II; type III ¼ radical hysterectomy
e sparing.
Table 5
Recurrence and survival data.
Reference Follow-up
period (mo)
Patients with recurrence,
n (%)
Mean time to
recurrence (mo)
Mean local
recurrence-free
survival (mo)
Mean
disease-free
survival (mo)
Cumulative disease-free survival rate
Sakuragi et al11 NS
Non-NS
29 (12e48) 1/22
e
e e 13e48
12e36
At 2 y
95.5%
100%
van den Tillaart
et al15
NS
Non-NS
24 8.3%
4.9%
13.3
11.7
11.6
11.9
22.0
22.7
2-y LFS and 5-y OS
Höckel et al16 41 (5e110) 3 (1.4%) (pelvis only)
2 (1.1%) (pelvic & distant)
5 (2.4%) (distant only)
e e e 5-y DFS
94%
98%
81%
5-y OS
96% (whole patients)
98% (stage IBeIIA; n ¼ 159)
91% (node positive; n ¼ 44)
Höckel17 45 (3e104) 4/163 (local recurrence)
2/163 (locoregional-distant)
4/163 (distant metastases)
e e e 3-y RFS
93%
98%
90%
3-y DSF
96% (whole group)
100% (low-risk group; n ¼ 68)
95% (high-risk group; n ¼ 95)
Querleu et al19 NS*
Non-NS**
26 (2e51)
41 (1e118)
3
4
e e e e
DFS ¼ disease-free survival; DSF ¼ disease-speciﬁc overall survival; LFS ¼ local recurrence-free survival; n ¼ number of patients; NS ¼ nerve sparing; NS* ¼ radical
hysterectomy with paracervical dissection; Non-NS** ¼ radical hysterectomy without paracervical dissection; OS ¼ overall survival; RFS ¼ recurrence-free survival.
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Sexual dysfunction complications (such as dyspareunia, vaginal
lubricant deﬁciency, insensibility of labial areas, discomfort or
dissatisfaction during sexual intercourse, etc) have been
described.31e33 Rees and associates reported that the radical pelvic
operation produced a degree of damage to the autonomic nerve
innervation of the blood vessels of the vaginal wall, which could be
related to the postoperative sexual function abnormality.33 Pieterse
et al34 analyzed the effect of the NSRH procedure on postsurgical
vaginal blood ﬂow, using photoplethysmographic assessment of the
vaginal pulse amplitude (VPA). Cervical cancer patients, who were
treated with the traditional radical hysterectomy, had a statistically
signiﬁcant lower mean VPA than premenopausal women and those
in thenerve sparinggroup. Inaddition, the studyconﬁrmed thatpre-
and postmenopausal women, with a history of conventional radical
hysterectomy, had a lower VPA outcome, similar to that in the
normal healthy postmenopausal control group. Pieterse et al
concluded that the conventional radical surgery procedure pro-
duced a lower vaginal blood ﬂow pattern, similar to the post-
menopausal population. The nerve sparingmethod canpreserve the
autonomic neural tissue, so the vaginal innervation related to sexual
function can be protected. Ditto et al used quality of life (QoL) scores,
with the function assessment of cancer therapy-cervix (FACT-Cx)
questionnaire, to evaluate organ function and quality of life in cer-
vical cancer patients who underwent Type II and Type III NSRH.35
The assessment of physical, functional, emotional, and social well-
being did not demonstrate signiﬁcant differences, but radio-
therapy seemed to be more effective than the surgical technique.
Conclusion
The NSRH procedure is a valuable method for reducing
treatment-related morbidity of extensive surgical procedures. It
has been reported that cancerous tissue can be removed to the
same degree as with the conventional radical hysterectomy
method. Also, the pelvic autonomic nervous tissue can be
conserved, which reduces long term complications. In institutes
with advanced surgical skill facilities, laparoscopic surgery is one of
the minimally invasive operative procedures that can be beneﬁcial
for cervical cancer patients; it depends on the patient’s factors and
physician’s experiences. However, the surgical advantage of NSRHfor improving the treatment quality in patients with cervical can-
cer, such as in terms of prognostic factors or bulky tumor status,
should be further studied.References
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